Treatment as prevention for HIV in China (Q43982496)

28 November 2017

Treatment as prevention for HIV in China (English)

1 reference

28 November 2017

prevention of HIV/AIDS

0 references

author

Sten Vermund

series ordinal

1

1 reference

PubMed ID

23206834

28 November 2017

language of work or name

English

0 references

publication date

1 December 2012

1 reference

28 November 2017

1 reference

28 November 2017

382

1 reference

28 November 2017

9899

1 reference

28 November 2017

1159-1161

1 reference

Prevention of HIV-1 infection with early antiretroviral therapy

28 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2962005-4

7 January 2021

Effect of antiviral treatment on the shedding of HIV-1 in semen

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2962005-4

7 January 2021

Virologic and immunologic determinants of heterosexual transmission of human immunodeficiency virus type 1 in Africa.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2962005-4

7 January 2021

Co-infection with HIV and hepatitis C virus in former plasma/blood donors: challenge for patient care in rural China

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2962005-4

7 January 2021

Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2962005-4

7 January 2021

Decreases in community viral load are accompanied by reductions in new HIV infections in San Francisco

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2962005-4

7 January 2021

Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2962005-4

7 January 2021

HIV treatment as prevention: the utility and limitations of ecological observation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2962005-4

7 January 2021

Syringe sharing and HIV incidence among injection drug users and increased access to sterile syringes.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2962005-4

7 January 2021

Antiretroviral therapy in prevention of HIV and TB: update on current research efforts

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2962005-4

7 January 2021

Combination HIV prevention: significance, challenges, and opportunities

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2962005-4

7 January 2021

ARVs as HIV Prevention: A Tough Road to Wide Impact

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2962005-4

7 January 2021

Universal testing and treatment as an HIV prevention strategy: research questions and methods

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2962005-4

7 January 2021

10.1016/S0140-6736(12)62005-4

Identifiers

DOI

1 reference

28 November 2017

1 reference

PubMed ID

23206834